Revita

BenStar · 2022 · $16.99 · Action · deal grade B

Measured on 2026-10-05 03:59 UTC. The whole catalog is re-measured daily; a game that just launched can move fast between passes.

Estimated net residual revenue: $362 to $543 per month
Opportunity: $724 per month at x1.60 dormancy
Estimated lifetime owners: 69.4k
81% positive across 2439 reviews · 4.3 reviews/month

Why it's flagged

Developer silent for 2.8 years
Studio quiet across its whole catalog
Last discounted 0 months ago, 12 sales in the last 12 months
Proven demand elasticity: x1.5 review velocity during past deep sales

Analyst notes (AI-assisted)

Note written 2026-09-05; the live figures above take precedence over any numbers in it.

Revita is a 2D action roguelike platformer built around health-as-currency mechanics, with bullet-hell boss fights and narrative depth.

Revita sits in a quiet phase with solid structural fundamentals: an engaged core audience (81% positive, median 35 hours), literary-grade storytelling callbacks, and recurring monthly residuals despite zero promotional activity in 12 months. The game is not dead, but developer communication has stalled for 32 months. For a publisher or studio seeking a low-risk catalog addition with locked-in fan loyalty and room for gentle revival (community DLC, console porting, or seasonal events), this represents an overlooked option. Acquisition upside is modest unless coupled with revival investment. Most realistic play: publishing.

Risk: Developer studio appears fading (one title, no public posts in 32 months); transfer of live-service support or content roadmap may require rebuilding institutional knowledge.
Risk: Niche roguelike platformer audience with no mainstream reach; growth ceiling is likely structural rather than addressable via marketing spend alone.
Risk: Player feedback highlights precision aiming and collision-detection frustration in tight 2D spaces; technical refinement may be prerequisite for retention uplift.

This case as Markdown · Estimates carry ±30-50% error per title.